Lilly spokesperson Antoinette Forbes said in a statement, Poison control centers, regulators, and patient advocacy groups around the country are issuing warnings about the use of compounded anti-obesity products. Many doctors are still uncertain, as well
Who is an ideal candidate for skin tightening treatments
doi: 10.1517/14656566.7.15.2095 143 PedrosaMRFrancoDRGieremekHWVidalCMBronzeriFde Cassia RochaAet al
FDA Approves Oral Semaglutide as the First GLP-1 Pill for Weight Loss The FDAs recent approval of oral semaglutide marks a revolutionary milestone in obesity medicine, introducing the first daily pill to deliver the powerful weight loss results previously restricted to injectable therapies
GaoXZhaoSDuYYangZTianYZhaoJet al
Some telehealth companies arent doing enough, he said, to make sure patients understand the risks or the complex delivery system associated with the injectable drugs